Strikingly, p16 mRNA levels were linearly correlated with the triglycerides to HDL ratio, a well-accepted marker of metabolic syndrome, coronary heart disease and colon adenoma risk (Fig. 1F)30–32. Here, CDKN2A is linked to colon adenoma.